MSL
GMED icon

Mackay Shields LLC’s Globus Medical GMED Stock Holding History

Mackay Shields LLC’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-78,500
Closed -$3.34M – 1501
2020
Q1 		$3.34M Sell
78,500
-3,500
-4% -$173K 0.03% 472
2019
Q4 		$4.83M Buy
82,000
+31,600
+63% +$1.72M 0.03% 474
2019
Q3 		$2.58M Buy
+50,400
New +$2.4M 0.02% 795
2019
Q1 		– Sell
-7,155
Closed -$309K – 1402
2018
Q4 		$309K Buy
+7,155
New +$357K ﹤0.01% 1244

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Mackay Shields LLC's GMED Position: Q2 2020 in Review

Mackay Shields LLC sold out of Globus Medical (GMED) in Q2 2020, closing a stake of 78,500 shares — an estimated $3.34M sold.

Mackay Shields LLC first reported a position in GMED in Q4 2018 and held it in 4 quarters. The position peaked at $4.83M in Q4 2019. 322 funds tracked by Wall St. Rank hold GMED as of Q2 2020.

  • Mackay Shields LLC reported no remaining Globus Medical position as of Q2 2020 after selling out during the quarter.
  • Mackay Shields LLC sold 78,500 Globus Medical shares in Q2 2020, an estimated $3.34M.
  • Mackay Shields LLC first reported a position in Globus Medical in Q4 2018 and held it in 4 quarters.
  • Mackay Shields LLC's Globus Medical position peaked at $4.83M in Q4 2019.
  • 322 funds tracked by Wall St. Rank held Globus Medical as of Q2 2020.

Based on Mackay Shields LLC's 13F filing for Q2 2020, filed 31 Jul 2020.